Loading stock data…
STVN
$17.71+0.71 (+4.18%)
Market ClosedLast close May 1
Stevanato Group S.p.A.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Stevanato Group S.p.A. in the Healthcare sector is trading at $17.71. The stock is currently 37% below its 52-week high of $28.00, remaining 14.3% below its 200-day moving average. Technical signals show overbought RSI of 88 and bullish MACD crossover, explaining why STVN maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 88) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$17.71
Potential Downside
23.3%
Whystock Fair Value$13.58
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus9 analysts
Buy
Mean target$24.72+39.6%
Range$17.50 – $32.00
Fundamentals
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.25B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
25.93
Beta
Defensive asset. Lower volatility than the S&P 500.
0.62
Div Yield
Strong income play. Yield provides a meaningful total return floor.
40.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.41%
Volume
Today's trading volume
485,456
Recent News
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here’s Why Stevanato Group Spa (STVN) Declined in Q1
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism about the domestic economy and attractive Small Cap valuations, but was impacted by volatility from Middle East geopolitical unrest and changing interest rate expectations. This unrest drove […]
Why The Stevanato Group (STVN) Investment Story Is Being Reset On GLP 1 And Biologics
Stevanato Group’s fair value estimate has been revised from US$28.78 to US$24.72, a cut of about 14% that resets expectations around the stock’s potential upside. Analysts linking this shift to lower GLP-1 guidance, softer Engineering orders, and differing views on how quickly current biologics strength turns into consistent earnings now span a wide target range of roughly US$19 to US$32. As you read on, you will see what is driving these views and how to keep track of the evolving Stevanato...
Stevanato Group’s (STVN) Core Business Improved Despite a 22% Pull Back in Q4
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 3.70% (gross) and 3.45% (net) in the fourth quarter compared to a 1.22% return for the Russell 2000 Growth Index. In 2025, the strategy […]
Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN)
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise characteristics, with strong earnings trajectories, and are trading at a discount to the estimated private market value. Despite strong results […]